Development of a new engineering-based capsule for human drug absorption studies.

[1]  N. Read,et al.  Effect of gastrointestinal intubation on the passage of a solid meal through the stomach and small intestine in humans. , 1983, Gastroenterology.

[2]  S. Davis,et al.  Alimentary tract andpancreas Transit ofpharmaceutical dosage forms through the , 1986 .

[3]  S. Davis,et al.  Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy. , 1988, British journal of clinical pharmacology.

[4]  L. Knutson,et al.  A new technique for segmental jejunal perfusion in man. , 1989, The American journal of gastroenterology.

[5]  U. Fuhr,et al.  Absorption of ipsapirone along the human gastrointestinal tract. , 1994, British journal of clinical pharmacology.

[6]  G L Amidon,et al.  Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption. , 1996, Advanced drug delivery reviews.

[7]  E. Doelker,et al.  Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery , 1996 .

[8]  U. Fuhr,et al.  Investigation of nifedipine absorption in different regions of the human gastrointestinal (GI) tract after simultaneous administration of 13C- and 12C-nifedipine , 1996, European Journal of Clinical Pharmacology.

[9]  I. Wilding.  Evolution of the biopharmaceutics classification system (BCS) to oral modified release (MR) formulations; what do we need to consider? , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[10]  Computer-controlled release of oxprenolol from capsules using small gas producing cells and electronic circuits , 1999 .

[11]  I. Wilding,et al.  Site-specific drug delivery in the gastrointestinal tract. , 2000, Critical reviews in therapeutic drug carrier systems.